The Role of B-TYPE NATRIURETIC PEPTIDE (BNP) AND Nterminal pro brain natriuretic peptide (NT-pro BNP) in Cardiology

Volume 20 No 13 (2022)

Huda D. Jabbar, Raid J. Mohammed, Mahmood R. Al-Haleem

DOI: 10.14704/nq.2022.20.13.NQ88292

Abstract

In recent years biomarkers have emerged as important tools for diagnosis, risk stratification and therapeutic decision making in cardiovascular diseases. Currently, several promising new biomarkers are under scientific investigation. Most of these new biomarkers, however, are not yet suitable for clinical application, with the exception of B-type natriuretic peptide (BNP) and its N- terminal fragment (NT-pro BNP). Both markers have proven their diagnostic usefulness in a great number of studies and thus have progressed from bench to clinical application. The aim of this article is to concisely review the diagnostic and prognostic role of BNP and NT-pro BNP in different cardiac diseases

Keywords

BNP, biomarkers, cardiology, NT-pro BNP, diagnostic, natriuretic peptide

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.